Federico Bertuzzi
Overview
Explore the profile of Federico Bertuzzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franch A, Knutsson K, Pedrotti E, Fasolo A, Bertuzzi F, Birattari F, et al.
Eur J Ophthalmol
. 2024 Nov;
:11206721241299470.
PMID: 39539150
Objectives: keratitis (AK) is a rare sight-threatening infectious disease with no approved pharmacological treatments Topical polihexanide 0.8 mg/ml (PHMB 0.08%) completed a pivotal clinical trial showing a medical cure rate...
2.
Galli A, Moretti S, Dule N, Di Cairano E, Castagna M, Marciani P, et al.
Am J Physiol Endocrinol Metab
. 2024 May;
327(1):E27-E41.
PMID: 38690938
Pancreatic endocrine cells employ a sophisticated system of paracrine and autocrine signals to synchronize their activities, including glutamate, which controls hormone release and β-cell viability by acting on glutamate receptors...
3.
Vergani M, Conti M, Lari A, Mion E, Bertuzzi F, Pintaudi B
Diabetes Res Clin Pract
. 2024 Apr;
210:111654.
PMID: 38574893
Aims: Several studies showed that Assisted Reproductive Technology (ART) could affect gestational diabetes mellitus (GDM) onset. The aim of this study was to estimate the prevalence of GDM risk factors...
4.
Chiereghin F, Pianazzola S, Mion E, Fumagalli G, Conti M, Vergani M, et al.
Diabet Med
. 2024 Feb;
41(6):e15311.
PMID: 38356191
No abstract available.
5.
Conti M, Massari G, Meneghini E, Pasquino B, Agosti B, Chinotti F, et al.
J Clin Med
. 2024 Feb;
13(3).
PMID: 38337336
Intermittently Scanned Continuous Glucose Monitoring (isCGM) devices are increasingly being used in patients with type 2 diabetes mellitus (T2DM) on insulin therapy for their benefits regarding disease management. Evidence of...
6.
Nani A, Bertuzzi F, Meneghini E, Mion E, Pintaudi B
J Clin Med
. 2023 Dec;
12(24).
PMID: 38137721
Type 2 diabetes mellitus (T2DM) is characterized by high blood glucose levels and lipid alterations. Besides pharmacological treatment, lifestyle modifications and nutraceuticals can be used to manage glucose and lipid...
7.
Conti M, Meneghini E, Fumagalli G, Guidoni F, Bertuzzi F, Pintaudi B
Acta Diabetol
. 2023 Aug;
60(12):1749-1752.
PMID: 37561210
No abstract available.
8.
Nani A, Carrara F, Paulesu C, Dalle Fratte C, Padroni M, Enisci S, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373652
Our aim was to evaluate osteomyelitis and other major lower limb safety outcomes (i.e., peripheral artery disease or PAD, ulcers, atraumatic fractures, amputations, symmetric polyneuropathy, and infections) in patients affected...
9.
Pintaudi B, Gironi I, Meneghini E, Conti M, Guidoni C, Di Vieste G, et al.
Diabetes Obes Metab
. 2023 Mar;
25(7):2034-2037.
PMID: 36932827
No abstract available.
10.
Marchini A, Ciulla M, Antonioli B, Agnoli A, Bovio U, Visnoviz V, et al.
Front Bioeng Biotechnol
. 2023 Mar;
11:1105157.
PMID: 36911193
Human pancreatic islets transplantation is an experimental therapeutic treatment for Type I Diabetes. Limited islets lifespan in culture remains the main drawback, due to the absence of native extracellular matrix...